MK-6482 show promising activity in ccRCC both as monotherapy and in combination with cabozantinib Feb. 19, 2021
Bionomics enters MoU with EmpathBio to explore combination of BNC-210 and EMP-01 for PTSD Feb. 19, 2021
GSK initiates phase III program with RSV vaccine candidate GSK-3844766A for older adults Feb. 18, 2021
U.K. clearance for first-in-human study of Avacta's FAP-activated doxorubicin prodrug AVA-6000 Feb. 18, 2021
RSS